Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 81, Issue 3, 2012, Pages 690-693

  Laine, Anne Laure ^a   Huynh, Ngoc Trinh ^a   Clavreul, Anne ^a,b   Balzeau, Julien ^c   Béjaud, Jérôme ^a   Vessieres, Anne ^d   Benoit, Jean Pierre ^a   Eyer, Joël ^c   Passirani, Catherine ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ D'ANGERS   (France)

^d PSL RESEARCH UNIVERSITY   (France)

Author keywords

Brain tumour; CED; Intra carotid injection; LNCs; NFL TBS peptide; OX26 MAb

Indexed keywords

FERROCENE DERIVATIVE; FERROCIPHENOL; LIPID; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OX26; NANOCAPSULE; PEPTIDE DERIVATIVE; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CANCER SURVIVAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; FEMALE; IC 50; NONHUMAN; RAT; SURVIVAL TIME;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; BINDING SITES; BRAIN NEOPLASMS; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; FEMALE; FERROUS COMPOUNDS; GLIOSARCOMA; INHIBITORY CONCENTRATION 50; LIPIDS; NANOCAPSULES; NEUROFILAMENT PROTEINS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED F344; RECEPTORS, TRANSFERRIN; SURVIVAL RATE; TUBULIN;

EID: 84863784284     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.04.012     Document Type: Article

References (10)

1. S.D. Caruthers, S.A. Wickline, G.M. Lanza, Nanotechnological applications in medicine, Curr. Opin. Biotechnol. 18 (2007) 26-30. (Pubitemid 46227971)
2. N.T. Huynh, C. Passirani, P. Saulnier, J.P. Benoit, Lipid nanocapsules: a new platform for nanomedicine, Int. J. Pharm. 379 (2009) 201-209.
3. E. Allard, N.T. Huynh, A. Vessières, P. Pigeon, G. Jaouen, J.-P. Benoit, C. Passirani, Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model, Int. J. Pharm. 379 (2009) 317-323.
4. W.A. Hall, Transferrin receptor on glioblastoma multiforme, J. Neurosurg. 74 (1991) 313-314.
5. K. Ulbrich, T. Hekmatara, E. Herbert, J. Kreuter, Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB), Eur. J. Pharm. Biopharm. 71 (2009) 251-256.
6. J. Huwyler, D. Wu, W.M. Pardridge, Brain drug delivery of small molecules using immunoliposomes, Proc. Nat. Acad. Sci. 93 (1996) 14164-14169. (Pubitemid 26424263)
7. A. Béduneau, F. Hindré, A. Clavreul, J.-C. Leroux, P. Saulnier, J.-P. Benoit, Brain targeting using novel lipid nanovectors, J. Control. Release 126 (2008) 44-49. (Pubitemid 351175685)
8. A. Bocquet, R. Berges, R. Frank, P. Robert, A.C. Peterson, J. Eyer, Neurofilaments bind tubulin and modulate its polymerization, J. Neurosci. 29 (2009) 11043-11054.
9. G. Jaouen, S. Top, A. Vessieres, G. Leclercq, J. Quivy, L. Jin, A. Croisy, The first organometallic antioestrogens and their antiproliferative effects, C. R. Acad. Sci. Ser. IIC Chem. 3 (2000) 89-93.
10. N.T. Huynh, C. Passirani, E. Allard-Vannier, L. Lemaire, J. Roux, E. Garcion, A. Vessieres, J.-P. Benoit, Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma, Int. J. Pharm. 423 (2012) 55-62.